Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Clinical trial NCT00474929 · COMPLETED
Trial details
- NCT number
- NCT00474929
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-29
- Primary completion
- 2011-11-05
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.